Paris Brain Institute is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
The Paris Brain Institute (Institut du Cerveau et de la Moelle épinière, ICM) is a translational research center dedicated to neurological and psychiatric diseases. Located at the Pitié-Salpêtrière Hospital in Paris, it brings together clinicians, researchers, and patients in a unique collaborative environment.
The Paris Brain Institute (Institut du Cerveau - ICM) was founded in 2010 as a major initiative in French neuroscience research, bringing together clinicians, researchers, and patients in a collaborative environment dedicated to understanding and treating neurological diseases. Located at the Pitié-Salpêtrière Hospital in Paris, the institute represents one of Europe's largest neuroscience research centers.
The institute's primary mission is to accelerate the translation of basic neuroscience discoveries into clinical applications for patients with neurodegenerative and neurological disorders. Research programs span from fundamental molecular and cellular studies to clinical trials and novel therapeutic approaches.
The institute coordinates numerous clinical trials across all major neurodegenerative diseases, with particular strength in:
The institute maintains state-of-the-art research facilities including:
The Paris Brain Institute maintains active partnerships with:
Research Focus
To understand the nervous system and develop new treatments for brain and spinal cord diseases through:
| Department | Focus |
|---|---|
| Neurodegenerative Diseases | AD, PD, ALS, HD, MS |
| Multiple Sclerosis | Immune-mediated demyelination |
| Parkinson's Disease | Motor complications, deep brain stimulation |
| Epilepsy | Seizure mechanisms, drug resistance |
| Mental Health | Depression, schizophrenia, bipolar |
The study of Paris Brain Institute has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.